Search
Acylcarnitine 10-Hydroxydodec-5-enedioylcarnitine
smpdb.ca/view/SMP0124031Metabolic10-Hydroxydodec-5-enedioylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-hydroxydodec-5-enedioyl-CoA reacts with L-carnitine to form 10-hydroxydodec-5-enedioylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5Acylcarnitine 5-Hydroxydodeca-7,9-dienoylcarnitine
smpdb.ca/view/SMP0124040Metabolic5-Hydroxydodeca-7,9-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 5-hydroxydodeca-7,9-dienoyl-CoA reacts with L-carnitine to form 5-hydroxydodeca-7,9-dienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5Acylcarnitine 5-Hydroxytrideca-8,11-dienoylcarnitine
smpdb.ca/view/SMP0124121Metabolic5-Hydroxytrideca-8,11-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 5-hydroxytrideca-8,11-dienoyl-CoA reacts with L-carnitine to form 5-hydroxytrideca-8,11-dienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5Acylcarnitine 5-Hydroxytrtradeca-7,9-dienoylcarnitine
smpdb.ca/view/SMP0124173Metabolic5-Hydroxytrtradeca-7,9-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 5-hydroxytrtradeca-7,9-dienoyl-CoA reacts with L-carnitine to form 5-hydroxytrtradeca-7,9-dienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreEnzymes: Solute carrier family 22 member 5DL-alpha tocopheryl acetate
go.drugbank.com/drugs/DB14477ApprovedMixtures: Folika-MG, Davimet-MCategories: Vitamin ETolfenamic acid
go.drugbank.com/drugs/DB09216ApprovedTolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory agent. … [L1292] In the US, it presents a Status class I by the FDA. By the European Medicine Agency, it was granted in 2016 with the status of orphan for the treatment of supranuclear palsy.[L1291]
Categories: Cytochrome P-450 Substrates, Non COX-2 selective NSAIDSProducts: TOLFEDINE TABLETS 6 MG, TOLFEDINE TABLET 60 MGPyrithione
go.drugbank.com/drugs/DB06815ApprovedInvestigationalWhile its use has been approved in the early 1960's by the FDA [A32163], safety and effectiveness of pyrithione zinc has been reported for decades. … In the crystalline state, it exists as a centrosymmetric dimer. Due to its dynamic fungistatic and bacteriostatic properties, pyrithione zinc is used to treat dandruff and seborrheic dermatitis.
Mixtures: MD CELL Scalp, Carione RgCategories: Heterocyclic Compounds, 1-RingBenzonatate
go.drugbank.com/drugs/DB00868Approved[L11193] Although it not prone to drug misuse or abuse, benzonatate is associated with a risk for severe toxicity and overdose, especially in children.[A189513] … [A5790] Currently, benzonatate is the only non-narcotic antitussive available as a prescription drug.
Synonyms: nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate, 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoateProducts: Benzonatate 100 mg, Benzonatate 200 mgNeratinib
go.drugbank.com/drugs/DB11828ApprovedInvestigationalNeratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. … Neratinib is currently under investigation for use in many other forms of cancer.
Categories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 SubstratesSynonyms: 奈拉替尼Vemurafenib
go.drugbank.com/drugs/DB08881ApprovedInvestigationalAfter approval, Roche in collaboration with Genentech launched a broad development program. [L1012] … [A31270] Vemurafenib was co-developed by Roche and Plexxikon and it obtained its FDA approval on August 17, 2011, under the company Hoffmann La Roche.
Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: ZELBORAF ® TABLETAS LACADAS DE 240 MG, ZELBORAF 240 MG FILM KAPLI TABLET ,56 FILM KAPLI TABLET